Three Australian researchers have received major research awards at the 2026 Annual Meeting of the American Academy of Optometry (AAO), on 2 October, in
Key Pharmaceuticals has launched Cyventine (cytisine 1.5 mg tablets), a nicotine-free, first-line smoking cessation aid11† for adults aged 18-65 years who want to stop
Hormone replacement therapy (HRT) may be associated with a decreased risk of developing age-related macular degeneration (AMD), according to researchers.
Nearly one in five people living with sight loss reported receiving or encountering eye treatments that they thought were “bogus”.
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
